We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AusPAR: Certolizumab pegol
Australian Public Assessment Report
Device/Product Name
Cimzia
Active ingredients
Certolizumab pegol
AusPAR Date
Published
Sponsor
Submission Number
PM-2017-04943-1-1
Submission Type
Major variation; extension of indications
Decision
Approved